Dosage and Adverse Effects of Topical Tacrolimus and Steroids in Daily Management of Atopic Dermatitis

Journal of Dermatology

Volumn 31, Issue 4, 2004, Pages 277-283

  Furue, Masutaka ^a,e   Terao, Hiroshi ^a   Moroi, Yoichi ^a   Koga, Tetsuya ^a   Kubota, Yumiko ^b   Nakayama, Juichiro ^b   Furukawa, Fukumi ^c   Tanaka, Yoichi ^d   Katayama, Ichiro ^d   Kinukawa, Naoko ^e   Nose, Yoshiaki ^e   Urabe, Kazunori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Dose, adverse effects; Topical steroids; Topical tacrolimus

Indexed keywords

STEROID; TACROLIMUS;

ACNE; ADULT; ARTICLE; ATOPIC DERMATITIS; DISEASE SEVERITY; DOSE CALCULATION; FEMALE; FOLLICULITIS; HERPES SIMPLEX; HUMAN; HYPERTRICHOSIS; MAJOR CLINICAL STUDY; MALE; MOLLUSCUM CONTAGIOSUM; MYCOSIS; SKIN ATROPHY; SKIN INFECTION; TELANGIECTASIA;

EID: 2342635897     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00673.x     Document Type: Article

References (18)

1. Williams HC: Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol, 17: 385-391, 1992.
2. Williams HC, Robertson C, Stewart A: Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood, J Allergy Clin Immunol, 103: 125-138, 1999.
3. Takeuchi M, Ueda H: Increase of atopic dermatitis (AD) in recent Japan, Envir Dermatol, 7: 133-136, 2000.
4. Sugiura H, Umemoto N, Deguchi H, et al: Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: Comparison with the disease frequency examined 20 years ago, Acta Dermato-Venereologica, 78: 293-294, 1998.
5. Brunsting LA: Atopic dermatitis (disseminated neurodermatitis) of young adults, Arch Derm Syph, 34: 935-957, 1936.
6. Furue M, Terao H, Rikihisa W, et al: Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis, Br J Dermatol, 148: 128-133, 2003.
7. Nakagawa H, Etoh T, Ishibashi Y, et al: Tacrolimus ointment for atopic dermatitis, Lancet, 344: 883, 1994.
8. Reitamo S, Rustin M, Ruzicka T, et al: Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis, J Allergy Clin Immunol, 109: 547-555, 2002.
9. Lazarous MC, Kerdel FA: Topical tacrolimus protopic, Drugs Today, 38: 7-15, 2002.
10. Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis, Jap J Dermatol, 106: 64-65, 1996.
11. Japanese FK-506 ointment study group: Long-term study of FK-506 (Tacrolimus) ointment in patients with atopic dermatitis-Analysis at the time of 1-year observation-, Rinsho Iyaku, 14: 2405-2432, 1998. (in Japanese)
12. Charman CR, Morris AD, Williams HC: Topical corticosteroid phobia in patients with atopic eczema, Br J Dermatol, 142: 931-936, 2000.
13. David TJ, Cambridge GC: Bacterial infection in atopic eczema, Arch Dis Child, 81: 20-23, 1986.
14. Bonifazi E, Garofalo L, Pisani V, Meneghini CL: Role of some infectious agents in atopic dermatitis, Acta Derm Venereol (Stockh), 114: 98-100, 1985.
15. Gianetti A: Viral skin diseases in atopic dermatitis, in Happle R, Grosshans E (eds): Pediatric Dermatology, Springer-Verlag, Berlin, 1987, p 110.
16. David TJ, Longson M: Herpes simplex infection in atopic eczema, Arch Dis Child, 60: 338-343, 1985.
17. Fleischer AB, Ling M, Eichenfield L, et al: Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections, J Am Acad Dermatol, 47: 562-570, 2002.
18. Griffiths WAD, Wilkinson JD: Topical therapy, in Champion RH, Burton JL, Burns DA, Breathnach SM (eds): Textbook of Dermatology, 6th ed, Blackwell Scientific Pub, Oxford, 1998, p 3519.